Composition
- Active ingredients
- ENFORTUMAB VEDOTIN-EJFV 30MG/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ENFORTUMAB VEDOTIN-EJFV 20MG/VIAL · InjectableBLA761137-001 · Prescription
- ENFORTUMAB VEDOTIN-EJFV 30MG/VIAL · InjectableThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761137.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Padcev
- Active substance
- enfortumab vedotin-ejfv
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Astellas
- Status
- Prescription
- FDA approval
- 18 Dec 2019
- Application
- BLA761137-002
- RxCUI
- 2268093



